Literature DB >> 18843127

Insights into inflammation and influenza.

Cameron Simmons1, Jeremy Farrar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18843127      PMCID： PMC2730541          DOI： 10.1056/NEJMcibr0805865

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Oseltamivir resistance during treatment of influenza A (H5N1) infection.

Authors:  Menno D de Jong; Tan Thanh Tran; Huu Khanh Truong; Minh Hien Vo; Gavin J D Smith; Vinh Chau Nguyen; Van Cam Bach; Tu Qui Phan; Quang Ha Do; Yi Guan; J S Malik Peiris; Tinh Hien Tran; Jeremy Farrar
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus.

Authors:  Bo-Jian Zheng; Kwok-Wah Chan; Yong-Ping Lin; Guang-Yu Zhao; Chris Chan; Hao-Jie Zhang; Hong-Lin Chen; Samson S Y Wong; Susanna K P Lau; Patrick C Y Woo; Kwok-Hung Chan; Dong-Yan Jin; Kwok-Yung Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

3.  Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection.

Authors:  Suki M Y Lee; Chung-Yan Cheung; John M Nicholls; Kenrie P Y Hui; Connie Y H Leung; Mongkol Uiprasertkul; George L Tipoe; Yu-Lung Lau; Leo L M Poon; Nancy Y Ip; Yi Guan; J S Malik Peiris
Journal:  J Infect Dis       Date:  2008-08-15       Impact factor: 5.226

4.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.

Authors:  Menno D de Jong; Cameron P Simmons; Tran Tan Thanh; Vo Minh Hien; Gavin J D Smith; Tran Nguyen Bich Chau; Dang Minh Hoang; Nguyen Van Vinh Chau; Truong Huu Khanh; Vo Cong Dong; Phan Tu Qui; Bach Van Cam; Do Quang Ha; Yi Guan; J S Malik Peiris; Nguyen Tran Chinh; Tran Tinh Hien; Jeremy Farrar
Journal:  Nat Med       Date:  2006-09-10       Impact factor: 53.440

5.  Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.

Authors:  Cameron P Simmons; Nadia L Bernasconi; Amorsolo L Suguitan; Kimberly Mills; Jerrold M Ward; Nguyen Van Vinh Chau; Tran Tinh Hien; Federica Sallusto; Do Quang Ha; Jeremy Farrar; Menno D de Jong; Antonio Lanzavecchia; Kanta Subbarao
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069
  5 in total
  16 in total

Review 1.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

2.  Effects of Buprenorphine Treatment on Influenza Pathogenesis in the Ferret (Mustela putorius furo).

Authors:  Victoria J Mrotz; Kaitlyn M Nestor; Taronna R Maines; Nathaniel Powell; Jessica A Belser
Journal:  Comp Med       Date:  2022-02-01       Impact factor: 1.565

3.  Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.

Authors:  Nathalie Lejal; Bogdan Tarus; Edwige Bouguyon; Sylvie Chenavas; Nicolas Bertho; Bernard Delmas; Rob W H Ruigrok; Carmelo Di Primo; Anny Slama-Schwok
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

Review 4.  Molecular imaging of influenza and other emerging respiratory viral infections.

Authors:  Mike Bray; James Lawler; Jason Paragas; Peter B Jahrling; Daniel J Mollura
Journal:  J Infect Dis       Date:  2011-03-21       Impact factor: 5.226

5.  Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults.

Authors:  Nelson Lee; Chun Kwok Wong; Paul K S Chan; Martin C W Chan; Rity Y K Wong; Samantha W M Lun; Karry L K Ngai; Grace C Y Lui; Bonnie C K Wong; Sharon K W Lee; Kin Wing Choi; David S C Hui
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

6.  Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model.

Authors:  Ching-Tai Huang; Chen-Yiu Hung; Tse-Ching Chen; Chun-Yen Lin; Yung-Chang Lin; Chia-Shiang Chang; Yueh-Chia He; Yu-Lin Huang; Avijit Dutta
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

7.  Meeting the challenge of influenza pandemic preparedness in developing countries.

Authors:  David S Fedson
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

Review 8.  Viral-bacterial interactions-therapeutic implications.

Authors:  Jane C Deng
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

Review 9.  Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.

Authors:  David S Fedson
Journal:  Influenza Other Respir Viruses       Date:  2009-07       Impact factor: 4.380

Review 10.  Review of Non-Bacterial Infections in Respiratory Medicine: Viral Pneumonia.

Authors:  José María Galván; Olga Rajas; Javier Aspa
Journal:  Arch Bronconeumol       Date:  2015-05-07       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.